Nuveen’s Aravive, Inc. Common Stock ARAV Stock Holding History

Nuveen’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-35,544	Closed	-$234K	–	3575
2021 Q1	$234K	Sell	35,544 -11,607	-25%	-$76.3K	﹤0.01%	3210
2020 Q4	$265K	Buy	47,151 +906	+2%	+$4.97K	﹤0.01%	3162
2020 Q3	$217K	Buy	46,245 +113	+0.2%	+$802	﹤0.01%	3152
2020 Q2	$537K	Buy	+46,132	New	+$547K	﹤0.01%	2869

Other funds holding ARAV

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen's ARAV Position: Q2 2021 in Review

Nuveen sold out of Aravive, Inc. Common Stock (ARAV) in Q2 2021, closing a stake of 35,544 shares — an estimated $234K sold.

Nuveen first reported a position in ARAV in Q2 2020 and held it in 4 quarters. The position peaked at $537K in Q2 2020. 49 funds tracked by Wall St. Rank hold ARAV as of Q2 2021.

Nuveen reported no remaining Aravive, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Nuveen sold 35,544 Aravive, Inc. Common Stock shares in Q2 2021, an estimated $234K.
Nuveen first reported a position in Aravive, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
Nuveen's Aravive, Inc. Common Stock position peaked at $537K in Q2 2020.
49 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.